Actively Recruiting

All Genders
NCT06897943

Epidemiology of Gonococcal Arthritis (EpGAr)

Led by University Hospital, Brest · Updated on 2025-03-27

11

Participants Needed

2

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this retrospective observational study was to describe the epidemiology of Neisseria gonorrhoeae septic arthritis over the last 10 years at Brest and Rennes university hospitals. The main question is whether there are any risk factors based on the epidemiological and clinical data on these cases. The second objective is to characterize the gonococcal strains isolated in order to determine whether there is a common clone, a virulence factor or specific resistance genes.

CONDITIONS

Official Title

Epidemiology of Gonococcal Arthritis (EpGAr)

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with a Neisseria gonorrhoeae-positive joint sample (from an enrichment vial or a native sample) between 2014 and 2024.
Not Eligible

You will not qualify if you...

  • Patients with Neisseria gonorrhoeae-negative joint sample (from enrichment vial or native sample).
  • Patients who have expressed opposition to inclusion in the study.
  • Patients under legal protection (guardianship, curatorship, etc.).

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Rennes University Hospital

Rennes, Brittany Region, France, 35000

Actively Recruiting

2

CHU de BREST

Brest, France, 29609

Actively Recruiting

Loading map...

Research Team

G

Geneviève HERY-ARNAUD

CONTACT

V

Valentin LEMOINE

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here